BusinessPostCorner.com
No Result
View All Result
Sunday, June 1, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughts

December 2, 2023
in Business
Reading Time: 2 mins read
A A
0
Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughts
ShareShareShareShareShare

The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.

The European Medicines Agency started investigating the issue in July after reports of suicidal thoughts and self-harm from people who had been taking the anti-obesity drugs. The review is focused on so-called GLP-1 treatments, a class that includes Novo’s Wegovy weight-loss shot as well as its diabetes medicine Ozempic. The drugs are among the hottest sellers in pharma.

In a statement Friday, the EMA’s safety committee said it had reviewed all clinical trial evidence and published literature on the subject, adding: “While at this point no conclusion can be drawn on a causal association, there are several issues that still need to be clarified.” 

The committee has agreed further lists of questions to be addressed by the makers of these medicines and said it will discuss the topic again at its meeting in April. 

Though their use for weight loss is comparatively recent, GLP-1 drugs have a more than 15-year history as treatments for diabetes. The EMA investigation also includes dulaglutide, the active ingredient in Lilly’s diabetes medicine Trulicity, and AstraZeneca Plc’s diabetes drug Byetta.

“Patient safety is Lilly’s top priority,” a spokesperson for the company told Bloomberg Friday. “We will continue to respond to the regulatory reviews regarding safety signals related to dulaglutide as part of our routine regulatory review processes.”

Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team. Sign up for free today.

Credit: Source link

ShareTweetSendPinShare
Previous Post

US, UK and Australia move to track ‘emerging threats’ in space

Next Post

Egg producers must pay at least $18 million in damages for price gouging in 2000s that involved conspiring to limit U.S. supplies

Next Post
Egg producers must pay at least  million in damages for price gouging in 2000s that involved conspiring to limit U.S. supplies

Egg producers must pay at least $18 million in damages for price gouging in 2000s that involved conspiring to limit U.S. supplies

Dubai Launches Tokenized Real Estate Platform, Eyes B in Property Digitization by 2033

Dubai Launches Tokenized Real Estate Platform, Eyes $16B in Property Digitization by 2033

May 26, 2025
Memorial Day 2025: What stores are open and closed?

Memorial Day 2025: What stores are open and closed?

May 26, 2025
South Korea’s Biggest Party Urges ‘Expedited KRW Stablecoin Rollout’

South Korea’s Biggest Party Urges ‘Expedited KRW Stablecoin Rollout’

May 25, 2025
White House moves to overturn ruling that Trump’s tariffs are illegal

White House moves to overturn ruling that Trump’s tariffs are illegal

May 29, 2025
To succeed at succession, ask yourself these hard questions

To succeed at succession, ask yourself these hard questions

May 29, 2025
Whoopi Goldberg, Halle Berry and other stars on how Hollywood treats Black women

Whoopi Goldberg, Halle Berry and other stars on how Hollywood treats Black women

May 28, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

How Iran is preparing for Israeli or US strikes

How Iran is preparing for Israeli or US strikes

June 1, 2025
Tough choices unavoidable, says IFS

Tough choices unavoidable, says IFS

May 31, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!